Assessment of HLA-DR high plasmablast (PB) frequencies in the TRIOMS cohort also showed a trend for increased PB frequencies in the TSO-treated group, while two of four placebo-treated controls rather experienced a decline in circulating PB cells over time ( Figure 3 f,g).
← all excerpts
The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled <i>Trichuris suis</i> Ova Immunotherapy.
1
—
—